Andre Altmann studied Computer Science at the RWTH Aachen Germany and later obtained a PhD in Computational Biology while working at the Max Planck Institute of Informatics in Saarbrücken, Germany. He held Postdoctoral fellowships at the Max Planck Institute for Psychiatry, Munich, Germany and at the Stanford University. His research focuses on understanding how molecular biology shapes brain function in healthy and diseased brains. Through the use of imaging genetics he approaches questions such as “which genes are responsible for variations in neural activity in the resting brain?” as well as “which processes are causing severe malfunctions leading to neuropsychiatric and neurodegenerative disorders such as Major Depressive Disorder and Alzheimer’s Disease?”.
His goal is to understand the molecular biology behind these disorders; down the road such an understanding may result in new drug candidates.
Furthermore, he is interested in developing disease biomarkers that assist in early detection of the disorder and in personalizing the treatment. Thus, his research interests are centered around topics in neuroimaging, molecular genetics, computational biology and machine learning